Search

Taking the Long VIEW in AMD

Lloyd Clark, MD

Show Description +

Since the completion of two parallel phase 3 randomized, double-masked, multicenter clinical trials, VIEW 1 and VIEW 2, long-term outcomes of aflibercept (Eylea, Regeneron) have been assessed in further clinical trials. In this installment of the AMD Resource Center, W. Lloyd Clark, MD, summarizes some of the results of an extension study that included patients from the VIEW 1 trial, which accumulated data out to 4 years of follow-up, and the 1-year interim results of a further 2-year treat-and-extend follow-up study called RANGE

Posted: 11/29/2016

Keywords:

Age-Related Macular Degeneration (AMD)

•

AMD Disease Education Resource Center

•

Clinical Cases

•

Wet AMD

Up Next

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

Stanislao Rizzo, MD

Pinhole Effect in Double Peel for Macular Hole

Pinhole Effect in Double Peel for Macular Hole

Hudson de Carvalho Nakamura, MD

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Frederic Aissani, MD

Macular Hole Surgery: Retinal Massager

Macular Hole Surgery: Retinal Massager

Manish Nagpal, MS, DO, FRCS(UK)

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Frederic Aissani, MD

The Big Mac: ILM Technique for Large Macular Holes

The Big Mac: ILM Technique for Large Macular Holes

Hudson Nakamura, MD

ILM Peel for Macular Hole Under Liquid PFC

ILM Peel for Macular Hole Under Liquid PFC

Hudson Nakamura, MD

My Peeling Technique for a Dense Plaque on the Posterior Capsule

My Peeling Technique for a Dense Plaque on the Posterior Capsule

Ashraf Armia, FRCSG, FACS

Experience a New Dimension: How Eyetube3D Works!

Experience a New Dimension: How Eyetube3D Works!

25-Gauge Vitrectomy for Retained Lens Fragments

25-Gauge Vitrectomy for Retained Lens Fragments

Yoreh Barak, MD, Lana Rifkin, MD, Omar Saleh, MD, Shlomit Schaal, MD, PhD

Taking the Long VIEW in AMD

Lloyd Clark, MD

Since the completion of two parallel phase 3 randomized, double-masked, multicenter clinical trials, VIEW 1 and VIEW 2, long-term outcomes of aflibercept (Eylea, Regeneron) have been assessed in further clinical trials. In this installment of the AMD Resource Center, W. Lloyd Clark, MD, summarizes some of the results of an extension study that included patients from the VIEW 1 trial, which accumulated data out to 4 years of follow-up, and the 1-year interim results of a further 2-year treat-and-extend follow-up study called RANGE

Posted: 11/29/2016

Keywords:

Age-Related Macular Degeneration (AMD)

•

AMD Disease Education Resource Center

•

Clinical Cases

•

Wet AMD

Please log in to leave a comment.

More in Retina

Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR

Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR

Jordan Deaner, MD; Rehan Hussain, MD; and Vaidehi Dedania, MD

Managing Endophthalmitis: Tap-and-Inject or Immediate Vitrectomy?

Managing Endophthalmitis: Tap-and-Inject or Immediate Vitrectomy?

Samir N. Patel, MD and Maria H. Berrocal, MD

Emily Y. Chew, MD, the 2025 Lifetime Achievement Awardee

Emily Y. Chew, MD, the 2025 Lifetime Achievement Awardee

Emily Y. Chew, MD and R.V. Paul Chan, MD, MSc, MBA

The Business of Retina at VBS

The Business of Retina at VBS

Esther L. Kim, MD and Basil K. Williams Jr, MD